
Franco-Nevada Co. (TSE:FNV – Free Report) (NYSE:FNV) – Scotiabank upped their FY2026 earnings estimates for shares of Franco-Nevada in a research report issued to clients and investors on Thursday, May 14th. Scotiabank analyst T. Jakusconek now expects that the company will earn $11.55 per share for the year, up from their prior forecast of $11.13. The consensus estimate for Franco-Nevada’s current full-year earnings is $3.11 per share.
Franco-Nevada (TSE:FNV – Get Free Report) (NYSE:FNV) last posted its quarterly earnings data on Tuesday, May 12th. The company reported C$3.31 EPS for the quarter. Franco-Nevada had a net margin of 61.07% and a return on equity of 16.25%. The firm had revenue of C$904.67 million for the quarter.
Get Our Latest Analysis on FNV
Franco-Nevada Trading Down 1.0%
TSE FNV opened at C$326.68 on Friday. Franco-Nevada has a 12 month low of C$210.19 and a 12 month high of C$388.22. The company has a debt-to-equity ratio of 0.11, a current ratio of 8.30 and a quick ratio of 23.26. The company has a market capitalization of C$63.00 billion, a price-to-earnings ratio of 46.01, a price-to-earnings-growth ratio of 5.00 and a beta of 0.97. The company’s fifty day moving average price is C$338.86 and its two-hundred day moving average price is C$319.00.
About Franco-Nevada
Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. Franco-Nevada’s short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital.
Further Reading
- Five stocks we like better than Franco-Nevada
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
Receive News & Ratings for Franco-Nevada Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Franco-Nevada and related companies with MarketBeat.com's FREE daily email newsletter.
